Effects of homeopathic treatment on salivary flow rate and subjective symptoms in patients with oral dryness: a randomized trial
Received13 September 2004
Received 21 June 2004
revised 19 July 2004
accepted 06 April 2005
29 December 2017 (online)
Twenty-eight patients with xerostomia participated in a blind, placebo-controlled longitudinal study of the possible effects of homeopathic medicines on oral discomfort. All patients were first divided in two groups according to their medication. After that the two groups were randomly assigned according to a coin-toss to the experimental or control group. Most patients had systemic diseases, such as rheumatoid arthritis and/or Sjögren's syndrome, and frequent daily medications. The randomly selected experimental group (n=15) got an individually prescribed homeopathic medicine and the control group (n=13) a placebo substance (sugar granules), both for 6 weeks. Neither group knew of the nature of the medicine. Oral dryness was evaluated by measurement of unstimulated and wax-stimulated salivary flow rates and visual analogue scale. With only two exceptions, the experimental group experienced a significant relief of xerostomia whereas no such effect was found in the placebo group. Stimulated salivary flow rate was slightly higher with homeopathy than placebo but no consistent changes occurred in salivary immunoglobulin (IgA, IgG) levels.
In an open follow-up period those receiving homeopathic medicine continued treatment and the placebo group patients were treated with individually prescribed homeopathic medicines. The symptoms of xerostomia improved in both groups.
Our results suggest that individually prescribed homeopathic medicine could be a valuable adjunct to the treatment of oral discomfort and xerostomic symptoms.
- 1 Herrera J.L, Lyons II M.F, Johnson L.F. Saliva: its role in health and disease. J Clin Gastroenterol 1988; 10: 569-578.
- 2 Ship J.A. Diagnosis, managing, and preventing salivary gland disorders. Oral Dis 2002; 8: 77-89.
- 3 Samarawickrama D.Y.D. Saliva substitutes: how effective and safe are they?. Oral Dis 2002; 8: 177-179.
- 4 Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 2002; 8: 23-29.
- 5 Sreebny L.M, Schwartz S.S. A reference guide to drugs and dry mouth, 2nd edn. Gerodontology 1997; 14: 33-47.
- 6 Närhi T.O. Prevalence of subjective feelings of dry mouth in the elderly. J Dent Res 1994; 73: 20-25.
- 7 Laine M, Leimola-Virtanen R. Effect of hormone replacement therapy on salivary flow rate, buffer effect and pH in perimenopausal and postmenopausal women. Archs Oral Biol 1996; 41: 91-96.
- 8 Sreebny L.M, Valdini A. Xerostomia, a neglected symptom. Arch Intern Med 1987; 147: 1333-1337.
- 9 Tenovuo J, Söderling E. Chemical aids in the prevention of dental diseases in the elderly. Int Dent J 1992; 42: 355-364.
- 10 Dodds M.W, Hsieh S.C, Johnson D.A. The effect of increased mastication by daily gum-chewing on salivary gland output and dental plaque acidogenicity. J Dent Res 1991; 70: 1474-1478.
- 11 Davies A.N. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med 2000; 14: 197-203.
- 12 Atkinson J.C, Baum B.J. Salivary enhancement: current status and future therapies. J Dent Educ 2001; 65: 1096-1101.
- 13 Blom M, Lundeberg T. Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis 2000; 6: 15-24.
- 14 Andersen S.W, Machin D. Acupuncture treatment of patients with radiation-induced xerostomia. Oral Oncol 1997; 33: 146-147.
- 15 Blom M, Dawidson I, Angmar-Månsson B. The effect of acupuncture on salivary flow rates in patients with xerostomia. Oral Surg Oral Med Oral Pathol 1992; 73: 293-298.
- 16 Heine H. Homotoxicology and ground regulation system (GRS). Baden-Baden, Germany: Aurelia-Verlag GmbH; 2000.
- 17 Thomson W.M, Chalmers J.M, Spencer A.J, Williams S.M. The xerostomia inventory: a multi-item approach to measuring dry mouth. Community Dent Health 1999; 16: 12-17.
- 18 Auterhoff G. Manufacture of investigational medicinal products. European Commission, Directorate-General III, Industry: Consumer goods industries, III/E/3: Pharmaceuticals. Pharm Ind 1997; 59: 121-124.
- 19 Lehtonen O.P, Gråhn E, Ståhlberg T, Laitinen L.A. Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infect Immun 1984; 43: 308-313.
- 20 Lowry O.H, Rosebrough N.J, Farr A.L, Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
- 21 Oberbaum M, Yaniv I, Ben-Gal Y, Stein J, Ben-Zvi N, Freedman L.S, Branski D. A randomised, controlled clinical trial of the homeopathic medication Traumeel SR in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 2001; 92: 684-690.